GC
AMGN icon

Gould Capital’s Amgen AMGN Stock Holding History

Gould Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-52
Closed -$14.7K – 202
2025
Q3 		$14.7K Sell
52
-68
-57% -$19.7K 0.01% 130
2025
Q2 		$33.5K Sell
120
-31
-21% -$8.78K 0.02% 94
2025
Q1 		$47K Sell
151
-135
-47% -$39.9K 0.03% 79
2024
Q4 		$74.5K Sell
286
-9,469
-97% -$2.81M 0.05% 66
2024
Q3 		$3.14M Sell
9,755
-177
-2% -$57.9K 2.07% 21
2024
Q2 		$3.1M Buy
+9,932
New +$2.92M 2.19% 16
2023
Q2 		– Sell
-119
Closed -$28.8K – 195
2023
Q1 		$28.8K Sell
119
-4,425
-97% -$1.09M 0.02% 101
2022
Q4 		$1.19M Sell
4,544
-59
-1% -$15.8K 0.95% 29
2022
Q3 		$1.04M Sell
4,603
-9
-0.2% -$2.18K 0.9% 30
2022
Q2 		$1.12M Sell
4,612
-203
-4% -$49.7K 0.9% 28
2022
Q1 		$1.16M Buy
4,815
+531
+12% +$122K 0.84% 30
2021
Q4 		$964K Buy
+4,284
New +$904K 0.67% 39

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Gould Capital's AMGN Position: Q4 2025 in Review

Gould Capital sold out of Amgen (AMGN) in Q4 2025, closing a stake of 52 shares — an estimated $14.7K sold.

Gould Capital first reported a position in AMGN in Q4 2021 and held it in 12 quarters. The position peaked at $3.14M in Q3 2024. 3,091 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Gould Capital reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Gould Capital sold 52 Amgen shares in Q4 2025, an estimated $14.7K.
  • Gould Capital first reported a position in Amgen in Q4 2021 and held it in 12 quarters.
  • Gould Capital's Amgen position peaked at $3.14M in Q3 2024.
  • 3,091 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Gould Capital's 13F filing for Q4 2025, filed 13 Feb 2026.